Related references
Note: Only part of the references are listed.G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)
Sergi Ferre et al.
PHARMACOLOGY & THERAPEUTICS (2022)
D1 dopamine receptors intrinsic activity and functional selectivity affect working memory in prefrontal cortex
Yang Yang et al.
MOLECULAR PSYCHIATRY (2021)
Regulation of dopamine-dependent transcription and cocaine action byGadd45b
Morgan E. Zipperly et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator (D1PAM), in Healthy Subjects
Darren Wilbraham et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes
Peng Xiao et al.
CELL (2021)
Structural insights into the human D1 and D2 dopamine receptor signaling complexes
Youwen Zhuang et al.
CELL (2021)
High-Content Single-Cell Fo euro rster Resonance Energy Transfer Imaging of Cultured Striatal Neurons Reveals Novel Cross-Talk in the Regulation of Nuclear Signaling by Protein Kinase A and Extracellular Signal-Regulated Kinase 1/2S
Jace Jones-Tabah et al.
MOLECULAR PHARMACOLOGY (2021)
Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist
Bingfa Sun et al.
NATURE COMMUNICATIONS (2021)
Dopaminergic D1 Receptor Stimulation Affects Effort and Risk Preferences
Alexander Soutschek et al.
BIOLOGICAL PSYCHIATRY (2020)
D1 Agonist Improved Movement of Parkinsonian Nonhuman Primates with Limited Dyskinesia Side Effects
Damon Young et al.
ACS CHEMICAL NEUROSCIENCE (2020)
A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
Rita Balice-Gordon et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease
Irene Sebastianutto et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Activation of D1 receptors affects human reactivity and flexibility to valued cues
Alexander Soutschek et al.
NEUROPSYCHOPHARMACOLOGY (2020)
The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia
Julia Castello et al.
SCIENTIFIC REPORTS (2020)
RasGRP1 is a causal factor in the development of L-DOPA-induced dyskinesia in Parkinson's disease
Mehdi Eshraghi et al.
SCIENCE ADVANCES (2020)
Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines
Rajan Giri et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation
Rouba Kozak et al.
FRONTIERS IN PHARMACOLOGY (2020)
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel et al.
FRONTIERS IN PHARMACOLOGY (2020)
A dopamine-induced gene expression signature regulates neuronal function and cocaine response
Katherine E. Savell et al.
SCIENCE ADVANCES (2020)
Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor
Ali I. Kaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration
Ahmed Hasbi et al.
NEUROBIOLOGY OF DISEASE (2020)
Dopamine D1 receptor signalling in dyskinetic Parkinsonian rats revealed by fiber photometry using FRET-based biosensors
Jace Jones-Tabah et al.
SCIENTIFIC REPORTS (2020)
PF-06649751 efficacy and safety in early Parkinson's disease: a randomized, placebo-controlled trial
Robert Riesenberg et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists
Michael L. Martini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods
Beatriz Bueschbell et al.
MOLECULES (2019)
The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice
Herbert Y. Meltzer et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex
Min Wang et al.
NEUROPHARMACOLOGY (2019)
Variable G protein determinants of GPCR coupling selectivity
Najeah Okashah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
被撤回的出版物: Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists (Retracted article. See vol. 13, pg. 989, 2022)
Pingyuan Wang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Illuminating G-Protein-Coupling Selectivity of GPCRs
Asuka Inoue et al.
CELL (2019)
A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia
Estibaliz Arce et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Striatal circuits for reward learning and decision-making
Julia Cox et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics
Daniel E. Felsing et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor
Junliang Hao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
β-arrestin2 alleviates L-dopa-induced dyskinesia via lower D1R activity in Parkinson's rats
Xing-Ru Zhang et al.
AGING-US (2019)
Cell-Type-Specific D1 Dopamine Receptor Modulation of Projection Neurons and Interneurons in the Prefrontal Cortex
Paul G. Anastasiades et al.
CEREBRAL CORTEX (2019)
Phosphorylation of Npas4 by MAPK Regulates Reward-Related Gene Expression and Behaviors
Yasuhiro Funahashi et al.
CELL REPORTS (2019)
Cocaine Self-administration Alters Transcriptome-wide Responses in the Brain's Reward Circuitry
Deena M. Walker et al.
BIOLOGICAL PSYCHIATRY (2018)
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Dopamine D1 Receptor Partial Agonist, PF-06669571, in Subjects with Idiopathic Parkinson's Disease
Rachel Gurrell et al.
CLINICAL DRUG INVESTIGATION (2018)
Switch-like PKA responses in the nucleus of striatal neurons
Cedric Yapo et al.
JOURNAL OF CELL SCIENCE (2018)
Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression
Giada Spigolon et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders
Robert F. Bruns et al.
NEUROPHARMACOLOGY (2018)
Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia
Kathryn Lanza et al.
NEUROPHARMACOLOGY (2018)
Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor
Hideaki Yano et al.
NATURE COMMUNICATIONS (2018)
Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
David L. Gray et al.
NATURE COMMUNICATIONS (2018)
Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia
Michael B. Ryan et al.
CELL REPORTS (2018)
Activation of Dopamine D1-D2 Receptor Complex Attenuates Cocaine Reward and Reinstatement of Cocaine-Seeking through Inhibition of DARPP-32, ERK, and Delta FosB
Ahmed Hasbi et al.
FRONTIERS IN PHARMACOLOGY (2018)
Two Forms of Synaptic Depression Produced by Differential Neuromodulation of Presynaptic Calcium Channels
Kenneth J. Burke et al.
NEURON (2018)
Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin
Irene Ruiz-DeDiego et al.
SCIENTIFIC REPORTS (2018)
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
Alberto J. Espay et al.
ANNALS OF NEUROLOGY (2018)
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization
Jennifer E. Davoren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Phase 1 Parkinson's Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated
U. Shivraj Sohur et al.
NEUROLOGY AND THERAPY (2018)
Evaluation of D-1/D-5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration
Spyros Papapetropoulos et al.
NEURODEGENERATIVE DISEASES (2018)
Dopamine D3 Receptor Modulates L-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling
Oscar Solis et al.
CEREBRAL CORTEX (2017)
Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation
Alberto J. Rico et al.
BRAIN STRUCTURE & FUNCTION (2017)
Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution
Akinori Nishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms
Pierre-Yves Jean-Charles et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy
Cristina Alcacer et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons
Cedric Yapo et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Non-motor features of Parkinson disease
Anthony H. V. Schapira et al.
NATURE REVIEWS NEUROSCIENCE (2017)
The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling
Yuri K. Peterson et al.
PHARMACOLOGICAL REVIEWS (2017)
Dopamine-Induced Changes in Gαolf Protein Levels in Striatonigral and Striatopallidal Medium Spiny Neurons Underlie the Genesis of L-DOPA-Induced Dyskinesia in Parkinsonian Mice
Ryoma Morigaki et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Antidyskinetic Effects of MEK Inhibitor Are Associated with Multiple Neurochemical Alterations in the Striatum of Hemiparkinsonian Rats
Guiqin Chen et al.
FRONTIERS IN NEUROSCIENCE (2017)
The Dopamine D5 Receptor Is Involved in Working Memory
Gregory V. Carr et al.
FRONTIERS IN PHARMACOLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Striatal dopamine D1 receptor suppression impairs reward -associative learning
Kerin K. Higa et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis
Kjell A. Svensson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia
Amy F. T. Arnsten et al.
BIOLOGICAL PSYCHIATRY (2017)
Differentiation of forebrain and hippocampal dopamine 1-class receptors, D1R and D5R, in spatial learning and memory
Joshua Sarinana et al.
HIPPOCAMPUS (2016)
A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ΔFosB Expression
Michael Feyder et al.
BIOLOGICAL PSYCHIATRY (2016)
Disruption of a dopamine receptor complex amplifies the actions of cocaine
Melissa L. Perreault et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
Ragy R. Girgis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease
Chiara Fiorentini et al.
MOVEMENT DISORDERS (2016)
Dopamine reward prediction-error signalling: a two-component response
Wolfram Schultz
NATURE REVIEWS NEUROSCIENCE (2016)
Gadd45β ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model
Hye-Yeon Park et al.
NEUROBIOLOGY OF DISEASE (2016)
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
Lauren Hirsch et al.
NEUROEPIDEMIOLOGY (2016)
Phosphoproteomics of the Dopamine Pathway Enables Discovery of Rap1 Activation as a Reward Signal In Vivo
Taku Nagai et al.
NEURON (2016)
Differential regulation of the phosphorylation of Trimethyl-lysine27 histone H3 at serine 28 in distinct populations of striatal projection neurons
Alessandra Bonito-Oliva et al.
NEUROPHARMACOLOGY (2016)
Dopamine receptor D5 deficiency results in a selective reduction of hippocampal NMDA receptor subunit NR2B expression and impaired memory
Rodrigo Moraga-Amaro et al.
NEUROPHARMACOLOGY (2016)
Reappraising striatal D1-and D2-neurons in reward and aversion
Carina Soares-Cunha et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Identification of G Protein-Biased Agonists That Fail To Recruit β-Arrestin or Promote Internalization of the D1 Dopamine Receptor
Jennie L. Conroy et al.
ACS CHEMICAL NEUROSCIENCE (2015)
The Roles of Central Amygdala D1 and D2 Receptors on Attentional Performance in a Five-Choice Task
Elizabeth S. Smith et al.
BEHAVIORAL NEUROSCIENCE (2015)
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia
Milica Cerovic et al.
BIOLOGICAL PSYCHIATRY (2015)
Activation of DREAM (Downstream Regulatory Element Antagonistic Modulator), a Calcium-Binding Protein, Reduces L-DOPA-Induced Dyskinesias in Mice
Irene Ruiz-DeDiego et al.
BIOLOGICAL PSYCHIATRY (2015)
Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions With Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
Nao J. Gamo et al.
BIOLOGICAL PSYCHIATRY (2015)
Rapid anti-depressant and anxiolytic actions following dopamine D1-D2 receptor heteromer inactivation
Maurice Y. F. Shen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Role of DNA Methylation in the Nucleus Accumbens in Incubation of Cocaine Craving
Renaud Massart et al.
JOURNAL OF NEUROSCIENCE (2015)
Evidence against dopamine D1/D2 receptor heteromers
A. L. Frederick et al.
MOLECULAR PSYCHIATRY (2015)
Dopaminergic regulation of olfactory type G-protein subunit expression in the striatum
I. Ruiz-DeDiego et al.
MOVEMENT DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
Nikhil M. Urs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Dopamine D1-like receptor signalling in the hippocampus and amygdala modulates the acquisition of contextual fear conditioning
Florence C. Heath et al.
PSYCHOPHARMACOLOGY (2015)
Stable G protein-effector complexes in striatal neurons: mechanism of assembly and role in neurotransmitter signaling
Keqiang Xie et al.
ELIFE (2015)
Dopamine receptors - IUPHAR Review 13
Jean-Martin Beaulieu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Effects of the D-1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder
Daniel R. Rosell et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders
Amy F. T. Arnsten et al.
PHARMACOLOGICAL REVIEWS (2015)
Dopamine D1/D5 Receptors Mediate Informational Saliency that Promotes Persistent Hippocampal Long-Term Plasticity
Niels Hansen et al.
CEREBRAL CORTEX (2014)
Inhibition of Adenylyl Cyclase Type 5 Prevents L-DOPA-Induced Dyskinesia in an Animal Model of Parkinson's Disease
Hye-Yeon Park et al.
JOURNAL OF NEUROSCIENCE (2014)
Mechanisms of Dopamine D1 Receptor-Mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5
Tim Fieblinger et al.
JOURNAL OF NEUROSCIENCE (2014)
Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
Melissa L. Perreault et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Selective Deletion of GRK2 Alters Psychostimulant-Induced Behaviors and Dopamine Neurotransmission
Tanya L. Daigle et al.
NEUROPSYCHOPHARMACOLOGY (2014)
DISTINCT DOPAMINERGIC CONTROL OF THE DIRECT AND INDIRECT PATHWAYS IN REWARD-BASED AND AVOIDANCE LEARNING BEHAVIORS
S. Nakanishi et al.
NEUROSCIENCE (2014)
Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for L-DOPA-induced dyskinesia
Cristina Alcacer et al.
NEUROSCIENCE LETTERS (2014)
Differential roles of the dopamine 1-class receptors, D1R and D5R, in hippocampal dependent memory
Joshua Sarinana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
Myriam Heiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dopamine Signaling Leads to Loss of Polycomb Repression and Aberrant Gene Activation in Experimental Parkinsonism
Erik Sodersten et al.
PLOS GENETICS (2014)
Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse
Emma Cahill et al.
FRONTIERS IN PHARMACOLOGY (2014)
Dopamine D1 Receptor Signaling: Does GαQ-Phospholipase C Actually Play a Role?
Sang-Min Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Constellation of HCN Channels and cAMP Regulating Proteins in Dendritic Spines of the Primate Prefrontal Cortex: Potential Substrate for Working Memory Deficits in Schizophrenia
Constantinos D. Paspalas et al.
CEREBRAL CORTEX (2013)
Striatal neurones have a specific ability to respond to phasic dopamine release
Liliana R. V. Castro et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease
Chiara Fiorentini et al.
NEUROBIOLOGY OF DISEASE (2013)
Consolidation of object recognition memory requires simultaneous activation of dopamine D1/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus
Janine I. Rossato et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2013)
Evaluation of D1 and D2 Dopamine Receptor Segregation in the Developing Striatum Using BAC Transgenic Mice
Dominic Thibault et al.
PLOS ONE (2013)
ERK regulation of phosphodiesterase 4 enhances dopamine-stimulated AMPA receptor membrane insertion
Roy S. Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Activation of protein kinase C is required for AMPA receptor GluR1 phosphorylation at serine 845 in the dorsal striatum following repeated cocaine administration
Jeong Hwan Oh et al.
PSYCHOPHARMACOLOGY (2013)
The Expanding Roles of Gβγ Subunits in G Protein-Coupled Receptor Signaling and Drug Action
Shahriar M. Khan et al.
PHARMACOLOGICAL REVIEWS (2013)
SKF83959 Is a Potent Allosteric Modulator of Sigma-1 Receptor
Lin Guo et al.
MOLECULAR PHARMACOLOGY (2013)
The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
Philippe Huot et al.
PHARMACOLOGICAL REVIEWS (2013)
D1-D2 Dopamine Receptor Synergy Promotes Calcium Signaling via Multiple Mechanisms
Lani S. Chun et al.
MOLECULAR PHARMACOLOGY (2013)
Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review
Michele Poletti et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
Molecular Mechanism of beta-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Eric Reiter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Designing prodrugs for the treatment of Parkinson's disease
Piera Sozio et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Dopamine- and cAMP-regulated Phosphoprotein of 32-kDa (DARPP-32)-dependent Activation of Extracellular Signal-regulated Kinase (ERK) and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Experimental Parkinsonism
Emanuela Santini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Gαolf Mutation Allows Parsing the Role of cAMP-Dependent and Extracellular Signal-Regulated Kinase-Dependent Signaling in L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
Cristina Alcacer et al.
JOURNAL OF NEUROSCIENCE (2012)
Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour
Vincent Pascoli et al.
NATURE (2012)
Comparison of the D1 dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease
John D. McCorvy et al.
PSYCHOPHARMACOLOGY (2012)
Contributions of ERK signaling in the striatum to instrumental learning and performance
Michael W. Shiflett et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Cytoplasmic tail of D1 dopaminergic receptor differentially regulates desensitization and phosphorylation by G protein-coupled receptor kinase 2 and 3
Keyvan Sedaghat et al.
CELLULAR SIGNALLING (2011)
VIP, CRF, and PACAP Act at Distinct Receptors to Elicit Different cAMP/PKA Dynamics in the Neocortex
Emilie Hu et al.
CEREBRAL CORTEX (2011)
Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway
Estefana Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The tyrosine phosphatase Shp-2 interacts with the dopamine D1 receptor and triggers D1-mediated Erk signaling in striatal neurons
Chiara Fiorentini et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Dorsal and ventral striatal protein synthesis inhibition affect reinforcer valuation but not the consolidation of instrumental learning
Sietse Jonkman et al.
LEARNING & MEMORY (2011)
PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B
Atsushi Baba et al.
NATURE CELL BIOLOGY (2011)
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Judith Y. Altarejos et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata
Claudia Rangel-Barajas et al.
NEUROBIOLOGY OF DISEASE (2011)
A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in Mice
Nikhil M. Urs et al.
NEUROPSYCHOPHARMACOLOGY (2011)
INHIBITION OF THE MAMMALIAN TARGET OF RAPAMYCIN PATHWAY BY RAPAMYCIN BLOCKS COCAINE-INDUCED LOCOMOTOR SENSITIZATION
J. Wu et al.
NEUROSCIENCE (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing
Priscilla Nga Ieng Lau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The dopamine D1-D2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in basal ganglia
Melissa L. Perreault et al.
FRONTIERS IN NEUROANATOMY (2011)
Identification of a specific assembly of the G protein Golf as a critical and regulated module of dopamine and adenosine-activated cAMP pathways in the striatum
Denis Herve
FRONTIERS IN NEUROANATOMY (2011)
Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
Mario Gustavo Murer et al.
FRONTIERS IN NEUROANATOMY (2011)
Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum
Emily L. Jocoy et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2011)
Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression
Anna R. Carta et al.
EXPERIMENTAL NEUROLOGY (2010)
Loss of the serum response factor in the dopamine system leads to hyperactivity
Jan Rodriguez Parkitna et al.
FASEB JOURNAL (2010)
The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons INCREASED HIGH AFFINITY STATE FOLLOWING AMPHETAMINE AND IN SCHIZOPHRENIA
Melissa L. Perreault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Adenosine A2A Receptor Signaling and Golf Assembly Show a Specific Requirement for the γ7 Subtype in the Striatum
William F. Schwindinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cyclin-dependent Kinase-9 Is a Component of the p300/GATA4 Complex Required for Phenylephrine-induced Hypertrophy in Cardiomyocytes
Yoichi Sunagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Associative Learning and CA3-CA1 Synaptic Plasticity Are Impaired in D1R Null, Drd1a-/- Mice and in Hippocampal siRNA Silenced Drd1a Mice
Oskar Ortiz et al.
JOURNAL OF NEUROSCIENCE (2010)
Polycomb Group Protein Displacement and Gene Activation through MSK-Dependent H3K27me3S28 Phosphorylation
Simmi Suman Gehani et al.
MOLECULAR CELL (2010)
Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat
Manon Lebel et al.
NEUROBIOLOGY OF DISEASE (2010)
OLFACTORY TYPE G-PROTEIN α SUBUNIT IN STRIOSOME-MATRIX DOPAMINE SYSTEMS IN ADULT MICE
W. Sako et al.
NEUROSCIENCE (2010)
AMPA RECEPTOR SUBUNIT GluR1 DOWNSTREAM OF D-1 DOPAMINE RECEPTOR STIMULATION IN NUCLEUS ACCUMBENS SHELL MEDIATES INCREASED DRUG REWARD MAGNITUDE IN FOOD-RESTRICTED RATS
K. D. Carra et al.
NEUROSCIENCE (2010)
Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine
Gemma Navarro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors
Helen S. Bateup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia
Stefania Fasano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists
Brooke M. Roberts et al.
PSYCHOPHARMACOLOGY (2010)
Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity
Ian Maze et al.
SCIENCE (2010)
Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease
Mohamed R. Ahmed et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons
Jian-Li Hu et al.
MOLECULAR BRAIN (2010)
The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum
Marcin Piechota et al.
GENOME BIOLOGY (2010)
Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease
Olivier Berton et al.
BIOLOGICAL PSYCHIATRY (2009)
Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA-Induced Dyskinesia and Histone Activation
Sanja Darmopil et al.
BIOLOGICAL PSYCHIATRY (2009)
Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) Controls Activation of Extracellular Signal-Regulated Kinase (ERK) Signaling in the Striatum and Long-Term Behavioral Responses to Cocaine
Stefania Fasano et al.
BIOLOGICAL PSYCHIATRY (2009)
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors
Carla Ferrada et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
D5 Dopamine Receptors are Required for Dopaminergic Activation of Phospholipase C
Asha Sahu et al.
MOLECULAR PHARMACOLOGY (2009)
Calcium Signaling by Dopamine D5 Receptor and D5-D2 Receptor Hetero-Oligomers Occurs by a Mechanism Distinct from That for Dopamine D1-D2 Receptor Hetero-Oligomers
Christopher H. So et al.
MOLECULAR PHARMACOLOGY (2009)
Genome-wide Analysis of Chromatin Regulation by Cocaine Reveals a Role for Sirtuins
William Renthal et al.
NEURON (2009)
Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: Effects of pramipexole and pergolide on working memory
Alberto Costa et al.
NEUROPSYCHOLOGIA (2009)
Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
Emanuela Santini et al.
SCIENCE SIGNALING (2009)
Identification of dopamine D1-D3 receptor heteromers -: Indications for a role of synergistic D1-D3 receptor interactions in the striatum
Daniel Marcellino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9:: Coexpression in dendritic spines and axon terminals
Jill R. Bordelon-Glausier et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons
Can Gao et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Dopamine D5 receptors:: A challenge to medicinal chemists
G. Giorgioni et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
A phosphatase cascade by which rewarding stimuli control nucleosomal response
Alexandre Stipanovich et al.
NATURE (2008)
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs
Helen S. Bateup et al.
NATURE NEUROSCIENCE (2008)
Cocaine regulates MEF2 to control synaptic and behavioral plasticity
Suprabha Pulipparacharuvil et al.
NEURON (2008)
Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling
Gerard J. O'Sullivan et al.
NEUROPHARMACOLOGY (2008)
D-1 but not D-5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus
Noelia Granado et al.
CEREBRAL CORTEX (2008)
Performance- and task-dependent effects of the dopamine D1/D5 receptor agonist SKF 38393 on learning and memory in the rat
Francesco Amico et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors
Jenny E. Westin et al.
BIOLOGICAL PSYCHIATRY (2007)
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia
Qiwen Mu et al.
SCHIZOPHRENIA RESEARCH (2007)
Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease
Hai Zhang et al.
NEUROPHARMACOLOGY (2007)
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia
Mark S. George et al.
SCHIZOPHRENIA RESEARCH (2007)
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia
Emanuela Santini et al.
JOURNAL OF NEUROSCIENCE (2007)
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
Bhomraj Thanvi et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Quantitative changes in Gαolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants
Jean-Christophe Corvol et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Dynamics of protein kinase A signaling at the membrane, in the cytosol, and in the nucleus of neurons in mouse brain slices
Nicolas Gervasi et al.
JOURNAL OF NEUROSCIENCE (2007)
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Susheel Vijayraghavan et al.
NATURE NEUROSCIENCE (2007)
Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56δ subunit
Jung-Hyuck Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum
Asim J. Rashid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Regulation of NMDA receptors by phosphorylation
Bo-Shiun Chen et al.
NEUROPHARMACOLOGY (2007)
Receptor recycling mediates plasma membrane recovery of dopamine D1 receptors in dendrites and axons after agonist-induced endocytosis in primary cultures of striatal neurons
Marie-Laure Martin-Negrier et al.
SYNAPSE (2006)
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'
Katsunori Tomiyama et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking
PJ Hallett et al.
JOURNAL OF NEUROSCIENCE (2006)
CREB modulates excitability of nucleus accumbens neurons
Y Dong et al.
NATURE NEUROSCIENCE (2006)
Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response element-binding protein-deficient mice
C Pittenger et al.
JOURNAL OF NEUROSCIENCE (2006)
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice
N Pavon et al.
BIOLOGICAL PSYCHIATRY (2006)
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease
R Cools
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum
AA Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells
MP Delghandi et al.
CELLULAR SIGNALLING (2005)
Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants:: Identification of D5:D2-like interactions
GJ O'Sullivan et al.
SYNAPSE (2005)
Pergolide effect on cognitive functions in early-mild Parkinson's disease
L Brusa et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum
E Valjent et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Instrumental learning, but not performance, requires dopamine d1-receptor activation in the amygdala
ME Andrzejewski et al.
NEUROSCIENCE (2005)
Increased D-1 dopamine receptor signaling in levodopa-induced dyskinesia
I Aubert et al.
ANNALS OF NEUROLOGY (2005)
Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons
LM Mao et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
The role of phosphorylation in D1 dopamine receptor desensitization -: Evidence for a novel mechanism of arrestin association
OJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Reduction in acetylcholine release in the hippocampus of dopamine D5 receptor-deficient mice
F Laplante et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal
SP Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
DARPP-32 anal modulation of cAMP signaling:: involvement in motor control and levodopa-induced dyskinesia
K Håkansson et al.
PARKINSONISM & RELATED DISORDERS (2004)
Modulation of dopamine mediated phosphorylation of AMPA receptors by PSD-95 and AKAP79/150
RD Swayze et al.
NEUROPHARMACOLOGY (2004)
Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice
EE Elliot et al.
PSYCHOPHARMACOLOGY (2003)
Keeping G proteins at bay:: A complex between G protein-coupled receptor kinase 2 and Gβγ
DT Lodowski et al.
SCIENCE (2003)
Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty
SM Li et al.
NATURE NEUROSCIENCE (2003)
SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain
LQ Jin et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans
CF Bartholomeusz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2003)
Loss of G protein γ7 alters behavior and reduces striatal αolf level and cAMP production
WF Schwindinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling
S Paul et al.
NATURE NEUROSCIENCE (2003)
Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype
A Rivera et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Early consolidation of instrumental learning requires protein synthesis in the nucleus accumbens
PJ Hernandez et al.
NATURE NEUROSCIENCE (2002)
D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase
CR Gerfen et al.
JOURNAL OF NEUROSCIENCE (2002)
Distinct residues in the carboxyl tail mediate agonist-induced desensitization and internalization of the human dopamine D1 receptor
M Lamey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Δ9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission
E Valjent et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Gαolf levels are regulated by receptor usage and control dopamine and adenosine action in the striatum
D Hervé et al.
JOURNAL OF NEUROSCIENCE (2001)
cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons
P Zanassi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease
MJ Hurley et al.
MOLECULAR BRAIN RESEARCH (2001)
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease
O Rascol et al.
ARCHIVES OF NEUROLOGY (2001)
DREAM-αCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription
F Ledo et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex
DA Henze et al.
JOURNAL OF NEUROPHYSIOLOGY (2000)
Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo
H Gurden et al.
JOURNAL OF NEUROSCIENCE (2000)
Amplification of dopaminergic signaling by a positive feedback loop
A Nishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Golfα mediates dopamine D1 receptor signaling
XX Zhuang et al.
JOURNAL OF NEUROSCIENCE (2000)
The dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway
S Paul et al.
JOURNAL OF NEUROSCIENCE (2000)
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
S Ginés et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation
AL Clayton et al.
EMBO JOURNAL (2000)
Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo
GL Snyder et al.
JOURNAL OF NEUROSCIENCE (2000)
Differential affinities of visual arrestin, βarrestin1, and βarrestin2 for G protein-coupled receptors delineate two major classes of receptors
RH Oakley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Dopamine D5 receptors of rat and human brain
ZU Khan et al.
NEUROSCIENCE (2000)
Share Paper
